Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 8/20 | 0.51 |
| ▸ | CA2 | P00918 | 8/20 | 0.51 |
| ▸ | CA12 | O43570 | 4/20 | 0.51 |
| ▸ | CA9 | Q16790 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28063880 | 0.98 | MEN1 (0.62) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL904074 | 0.94 | TDP1 (0.66) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL12680329 | 0.93 | MEN1 (0.57) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL7911543 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL22276615 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL2702010 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL826376 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL22276602 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL16487196 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL826329 | 0.93 | TDP1 (0.69) | MEN1GAAKMT2ATDP1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2399 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010913-A | Rhodamine-marked isoquinoline derivative and preparation method and application thereof | 淮阴师范学院 | 2026-05-12 | — | — | CN | claimed |
| CN-119143776-B | Small-molecule fluorescent probe compound and preparation method and application thereof | 中国药科大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119143776-A | Small-molecule fluorescent probe compound and preparation method and application thereof | 中国药科大学 | 2024-12-17 | — | — | CN | claimed |
| CN-118894858-A | BRD4/PLK1 double-target small molecule fluorescent probe and preparation method and application thereof | 山东第一医科大学(山东省医学科学院) | 2024-11-05 | — | — | CN | claimed |
| CN-118662656-A | Releasable S02Macromolecular vesicles of (2), and preparation method and application thereof | 上海大学 | 2024-09-20 | — | — | CN | claimed |
| CN-118546199-A | Preparation method of prostate cancer targeted fluorescent contrast agent, reagent and application of contrast agent and reagent | 新斗生物科技(苏州)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-117534721-A | Preparation method of hederagenin derivative | 烟台大学 | 2024-02-09 | — | — | CN | claimed |
| CN-117362387-A | Benzenesulfonamide piperazinone glycine derivative as well as preparation method and application thereof | 山东大学 | 2024-01-09 | — | — | CN | claimed |
| CN-113512035-B | Dihydropyrimidine-pomalidomide conjugate, and preparation method and application thereof | 山东大学 | 2023-11-24 | — | — | CN | claimed |
| CN-117025699-A | Synthesis method of larotinib key intermediate | 泰州学院 | 2023-11-10 | — | — | CN | claimed |
| CN-105814031-A | Sulfonates of furan-2,5-dimethanol and (tetrahydrofuran-2,5-diyl)dimethanol and derivatives thereof | 阿彻丹尼尔斯米德兰德公司 | 2016-07-27 | — | — | CN | claimed |
| WO-2016029146-A1 | SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE | UNIVERSITY OF WASHINGTON (US) | 2016-02-25 | — | — | WO | claimed |
| CN-104497095-A | Epandrosterone and dehydroepiandrosterone derivatives, preparation method thereof, and applications of derivatives in preparation of drugs used for preventing breast cancer | UNIV EAST CHINA NORMAL | 2015-04-08 | — | — | CN | claimed |
| US-20140309192-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC, | 2014-10-16 | — | — | US | claimed |
| US-20100311694-A1 | Set of Geldanamycin Derivatives and Their Preparation Methods | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2010-12-09 | — | — | US | claimed |
| EP-2253621-A1 | A SET OF GELDANAMYCIN DERIVATIVES AND THEIR PREPARATION METHODS | Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) | 2010-11-24 | — | — | EP | claimed |
| EP-0934065-B1 | NOVEL CRYPTOPHYCIN DERIVATIVES AS ANTI-NEOPLASTIC AGENTS | UNIV HAWAII (US) | 2006-06-07 | — | — | EP | claimed |
| US-6680311-B1 | ANTICARCINOGENIC, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS | ELI LILLY AND COMPANY | 2004-01-20 | — | — | US | claimed |
| US-6004823-A | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 1999-12-21 | — | — | US | claimed |
| CN-1233957-A | Pharmaceutical compositions | LILLY CO ELI (US) | 1999-11-03 | — | — | CN | claimed |